Report cover image

U.S. Artemisinic Acid Market Size, Share & Trends Analysis Report By Product (Antimalarial Injections, Antimalarial Tablets), And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Oct 03, 2025
Length 80 Pages
SKU # GV20574958

Description

U.S. Artemisinic Acid Market Summary

The U.S. artemisinic acid market size was estimated at USD 236.6 million in 2024 and is projected to reach USD 367.7 million by 2033, growing at a CAGR of 5.0% from 2025 to 2033. The primary factors driving the U.S. artemisinic acid market include an increase in malaria cases connected to international travel, the rising global resistance to traditional antimalarials, government-supported stockpiling initiatives, and expanded research and development in semi-synthetic production methods.

The rise of Plasmodium falciparum strains resistant to traditional antimalarial drugs in Africa and Southeast Asia is prompting healthcare providers and policymakers to prioritize access to fast-acting artemisinin-based treatments. As resistance patterns evolve, U.S. institutions increase their reliance on advanced artemisinic formulations, driving imports, R&D investment, and stockpiling of effective therapies to ensure readiness against more virulent malaria forms.

Furthermore, biotechnology innovations such as engineered Saccharomyces cerevisiae (yeast)-have enabled more stable and scalable production of artemisinic acid. This reduces reliance on agricultural sources such as Artemisia annua, vulnerable to climate and yield variability. As pharmaceutical companies adopt these methods, the U.S. market benefits from enhanced production reliability and cost-efficiency, supporting broader distribution and emergency preparedness.

U.S. Artemisinic Acid Market Report Segmentation

This report forecasts revenue growth at U.S. artemisinic acid market and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artemisinic acid market report based on product.
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Antimalarial Injections
  • Antimalarial Tablets
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

80 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. U.S. Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Artemisinic Acid Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. Artemisinic Acid Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
Chapter 4. U.S. Artemisinic Acid Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Artemisinic Acid Market: Product Movement Analysis
4.3. U.S. Artemisinic Acid Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
4.4. Antimalarial Tablets
4.4.1. Antimalarial Tablets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Antimalarial Injections
4.5.1. Antimalarial Injections Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Competitive Landscape
5.1. Market Participant Categorization
5.2. Company Market Position Analysis/ Heap Map Analysis
5.3. Company Profiles
5.3.1. Sanofi
5.3.1.1. Participant’s Overview
5.3.1.2. Financial Performance
5.3.1.3. Product Benchmarking
5.3.1.4. Strategic Initiatives
5.3.2. KPC Pharmaceuticals, Inc.
5.3.2.1. Participant’s Overview
5.3.2.2. Financial Performance
5.3.2.3. Product Benchmarking
5.3.2.4. Strategic Initiatives
5.3.3. Guilin Pharmaceuticals Co,. Ltd.
5.3.3.1. Participant’s Overview
5.3.3.2. Financial Performance
5.3.3.3. Product Benchmarking
5.3.3.4. Strategic Initiatives
5.3.4. Calyx Chemicals and Pharmaceuticals Ltd.
5.3.4.1. Participant’s Overview
5.3.4.2. Financial Performance
5.3.4.3. Product Benchmarking
5.3.4.4. Strategic Initiatives
5.3.5. Novartis Pharmaceuticals Corporation
5.3.5.1. Participant’s Overview
5.3.5.2. Financial Performance
5.3.5.3. Product Benchmarking
5.3.5.4. Strategic Initiatives
5.3.6. Ipca Laboratories Inc.
5.3.6.1. Participant’s Overview
5.3.6.2. Financial Performance
5.3.6.3. Product Benchmarking
5.3.6.4. Strategic Initiatives
5.3.7. Cipla USA Inc.
5.3.7.1. Participant’s Overview
5.3.7.2. Financial Performance
5.3.7.3. Product Benchmarking
5.3.7.4. Strategic Initiatives
5.3.8. SHINPOONG CO. Ltd.
5.3.8.1. Participant’s Overview
5.3.8.2. Financial Performance
5.3.8.3. Product Benchmarking
5.3.8.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us